Mode
Text Size
Log in / Sign up

Pancreatic diseases

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for pancreatic diseases

9 trials tracked for pancreatic diseases: 5 in phase 3 or 4 and 3 with published results. The most-cited published study has 132 citations.

9Trials tracked
5Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 2 Phase 3 3 Phase 2 1 Other / NA 3
  1. Phase 3 Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) Completed · 132 cited
  2. Phase 3 Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? Completed · 120 cited
  3. Phase 4 IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Completed · 11 cited
  4. Phase 4 Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy Completed
  5. Phase 3 Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP) Completed
  6. Phase 2 A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer Completed
Show 3 more trials
  1. N/A Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed
  2. N/A Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency Completed
  3. N/A Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.